AIM: To review and summarize evidence from longitudinal studies on the association between serum 25-hydroxyvitamin D (25(OH)D) and the risk of prostate cancer (PC). METHODS: Relevant prospective cohort studies and nested case-control studies published until July 2009 were identified by systematically searching Ovid Medline, EMBASE, and ISI Web of Knowledge databases and by cross-referencing. The following data were extracted in a standardized manner from eligible studies: first author, publication year, country, study design, characteristics of the study population, duration of follow-up, PC incidence/PC mortality according to serum vitamin D status and the respective risk ratios, and covariates adjusted for in the analysis. Due to the heterogeneity of studies in categorizing serum vitamin D levels, all results were recalculated for an increase in serum 25(OH)D by 10ng/ml. Summary odds ratios (ORs) were calculated using meta-analysis methods. RESULTS: Overall, eleven original articles were included, ten of which reported on the association between serum vitamin D levels and PC incidence and one article reported on the association with PC mortality. Meta-analysis of studies on PC incidence resulted in a summary OR (95% confidence interval, CI) of 1.03 (0.96-1.11) associated with an increase of 25(OH)D by 10ng/ml (P=0.362). No indication for heterogeneity and publication bias was found. CONCLUSIONS: According to available evidence from longitudinal studies, serum 25(OH)D is not associated with PC incidence.
AIM: To review and summarize evidence from longitudinal studies on the association between serum 25-hydroxyvitamin D (25(OH)D) and the risk of prostate cancer (PC). METHODS: Relevant prospective cohort studies and nested case-control studies published until July 2009 were identified by systematically searching Ovid Medline, EMBASE, and ISI Web of Knowledge databases and by cross-referencing. The following data were extracted in a standardized manner from eligible studies: first author, publication year, country, study design, characteristics of the study population, duration of follow-up, PC incidence/PC mortality according to serum vitamin D status and the respective risk ratios, and covariates adjusted for in the analysis. Due to the heterogeneity of studies in categorizing serum vitamin D levels, all results were recalculated for an increase in serum 25(OH)D by 10ng/ml. Summary odds ratios (ORs) were calculated using meta-analysis methods. RESULTS: Overall, eleven original articles were included, ten of which reported on the association between serum vitamin D levels and PC incidence and one article reported on the association with PC mortality. Meta-analysis of studies on PC incidence resulted in a summary OR (95% confidence interval, CI) of 1.03 (0.96-1.11) associated with an increase of 25(OH)D by 10ng/ml (P=0.362). No indication for heterogeneity and publication bias was found. CONCLUSIONS: According to available evidence from longitudinal studies, serum 25(OH)D is not associated with PC incidence.
Authors: María Elena Martínez; Elizabeth T Jacobs; John A Baron; James R Marshall; Tim Byers Journal: J Natl Cancer Inst Date: 2012-04-25 Impact factor: 13.506
Authors: Kathleen Torkko; Cathee Till; Catherine M Tangen; Phyllis J Goodman; Xiaoling Song; Jeannette M Schenk; M Scott Lucia; Ulrike Peters; Adrie van Bokhoven; Ian M Thompson; Marian L Neuhouser Journal: Cancer Prev Res (Phila) Date: 2020-02-26
Authors: Rebecca Gilbert; Chris Metcalfe; William D Fraser; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin Journal: Int J Cancer Date: 2011-12-21 Impact factor: 7.396
Authors: Alison M Mondul; Irene M Shui; Kai Yu; Ruth C Travis; Victoria L Stevens; Daniele Campa; Frederick R Schumacher; Regina G Ziegler; H Bas Bueno-de-Mesquita; Sonja Berndt; E D Crawford; Susan M Gapstur; J Michael Gaziano; Edward Giovannucci; Christopher A Haiman; Brian E Henderson; David J Hunter; Mattias Johansson; Timothy J Key; Loïc Le Marchand; Sara Lindström; Marjorie L McCullough; Carmen Navarro; Kim Overvad; Domenico Palli; Mark Purdue; Meir J Stampfer; Stephanie J Weinstein; Walter C Willett; Meredith Yeager; Stephen J Chanock; Dimitrios Trichopoulos; Laurence N Kolonel; Peter Kraft; Demetrius Albanes Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-02-01 Impact factor: 4.254